期刊文献+

不同病因脾功能亢进患者骨髓造血容积的比较分析 被引量:2

Difference of haematogenesis volume between patients with hypersplenism of different etiopathogenisis
下载PDF
导出
摘要 目的:比较乙肝后肝硬化和血吸虫肝纤维化脾功能亢进患者骨髓容积的差异,探讨骨髓代偿性增生在不同原因脾功能亢进诊断中的意义。方法:对乙肝后肝硬化和血吸虫肝纤维化脾功能亢进患者行骨髓穿刺及活检,记录每高倍视野下有核细胞数。活检组织石蜡包埋制作切片,网形测微器计数法计算骨髓造血容积比例。结果:乙肝后肝硬化组患者骨髓细胞涂片每高倍视野下有核细胞数为(43.32±22.51)个,骨髓活检造血容积为(38.44±21.45)%,均显著低于血吸虫肝纤维化组的(72.59±17.90)个和(58.73±12.21)%(P<0.01)。结论:乙肝后肝硬化脾功能亢进患者骨髓造血容积可能低下,不能作为诊断重要标准。 Objective: To compare the difference of haematogenesis volume in bone marrow between hypersplenism patients with hepatic cirrhosis caused by HB virus or hepatic fibrosis caused by schistosome respectively,and to investigate the meaning of bone marrow compensatory hyperplasia in the diagnosis of hypersplenism. Methods:Bone marrow aspiration and biopsy were performed in the patients,nucleated cells per highpower field were counted. Bone marrow tissue was sliced after paraffin imbedding, Haematogenesis volume was calculated by using a netshape micrometer. Resutls: The mean age of patients with post-HB liver cirrhosis was younger than that with postschistosome hepatic fibrosis,and howerer,the number of nucleated cells per high-power field of patients with post-HB hepatic cirrhosis was 43.32±22.51,and bone marrow haematogenesis volume was(38.44±21.45)% ,with both lower than patients with post - schistosome hepatic fibrosis significantly (72. 59 ±17. 90) and (58. 73±12. 21) %, respectively (P 〈0.01). Conclusion: Lower haematogenesis volume in the bone marrow may occur in patients with hypersplenism caused by post-HB liver cirrhosis,which,as a major criterion,is improper in the diagnosis.
出处 《黑龙江医药科学》 2007年第4期27-28,共2页 Heilongjiang Medicine and Pharmacy
关键词 肝硬化 乙肝后 肝纤维化 血吸虫 脾功能亢进 骨髓造血容积 liver cirrhosis, post - HB hepatic fibrosis, schistosomal hypersplenism bone marrow compensatory hyperplasia
  • 相关文献

参考文献3

二级参考文献3

  • 1Wong K F,Hum Pathol,1996年,27卷,1239页
  • 2袁则,中华儿科杂志,1994年,32卷,377页
  • 3Wong K F,Am J Med,1992年,93卷,177页

共引文献37

同被引文献30

  • 1张伟辉,赵松,付英梅,刘连新,王晓春,武林枫.肝硬化门静脉高压症患者脾切除术后血细胞数减少的病因分析[J].中华医学杂志,2005,85(18):1285-1286. 被引量:9
  • 2何凤萍,黄文勇,欧书明,罗卫民.肝硬化血细胞减少骨髓形态学特点探讨[J].中国医师杂志,2007,9(1):110-111. 被引量:5
  • 3唐锦治.肝脏病与其他系统疾病的相互关系//黄铭新.内科理论与实践[M].上海:上海科学技术出版社.1988:392-518.
  • 4Qamar AA, Grace ND, Groszmann R, et al. Incidence, prevalence,and clinical significance of abonormal hemato- logic indices in compensated cirrhosis [J]. Clin Gastroenterol Hepatol, 2009, 7(6): 689-695.
  • 5Weksler BB. Review article: the pathophysiology of thromb- ocytopenia in hepatitis C virus infection and chronic liver disease [J]. Aliment Pharmacol Ther, 2007, 26(1): 13-19.
  • 6Rios R, Sangro B, Herrero I, et al. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis [J]. Am J Gastroenterol , 2005, 100(6): 1311-1316.
  • 7Peck-Radosavljevic M, Zacherl J, Meng YG, et al. Is inad- equate thrombopoietin production a major cause of thromb- ocytopenia in cirrhosis of the liver? [J]. J Hepatol, 1997, 27 (1): 127-131.
  • 8Martin TG 3rd, Somberg KA, Meng YG, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation [J]. Ann Intern Med, 1997, 127(4): 285- 288.
  • 9Gurakar A, Fagiuoli S, Gavaler JS, et al. The use of granulo- cyte-macrophage colony-stimulating factor to enhance he- matologic parameters of patients with cirrhosis and hyper- splenism [J]. J Hepatol, 1994, 21(4): 582-586.
  • 10Kubota A, Okamura S, Omori F, et al. High serum levels of granulocyte-macrophage colony-stimulating factor in patients with liver cirrhosis and granulocytopenia [J]. Clin Lab Haematol, 1995, 17(1): 61-63.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部